查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434627

脫髮症治療藥物市場：按脫髮症類型、性別、給藥途徑- 全球預測 2024-2030

Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年脫髮症藥物市場規模為12.3億美元，預計2024年將達到13.7億美元，2030年將達到27億美元，複合年成長率為11.90%。

全球脫髮症治療市場

主要市場統計
基準年[2023] 12.3億美元
預測年份 [2024] 13.7億美元
預測年份 [2030] 27億美元
複合年成長率（%） 11.90%
脫髮治療藥物市場-IMG1

脫髮症是一種身體任何部位（包括頭皮）脫髮的疾病，男性和女性都會受到影響。脫髮症藥物可作為藥物干預措施，防止進一步脫髮、促進脫髮再生或解決根本原因。例如，Finasteride主要用於治療男性雄性脫髮症，並抑制 5-α 還原酶，將睪固酮轉化為二氫睪固酮 (DHT) 的酶。另一方面，米諾地爾是一種血管擴張劑，最初是為了治療高血壓而開發的，已被證明可以促進男性和女性的頭髮生長。此外，正在研究新的方法，包括針對參與免疫訊號途徑的Janus激酶蛋白的 JAK 抑制劑，以及利用自體血液樣本中的生長因子的富血小板血漿療法。由於自體自體免疫疾病的迅速增加、不健康的生活習慣以及缺乏運動導致全球脫髮症，全球脫髮治療市場正在顯著成長。此外，許多非政府組織正在積極努力提高人們對脫髮症的意識提升，進一步促進市場成長。然而，對脫髮症治療對健康的負面影響和功效的擔憂正在限制市場的擴張。此外，人們對植髮和美容療程的日益偏好也可能阻礙藥物干預措施的採用。同時，監管機構對脫髮症新型系統療法的核准不斷增加，為市場進入者提供了利潤豐厚的機會。此外，斑禿治療脫髮症正在進行的研究和開發活動為未來的進步提供了廣闊的前景。

區域洞察

在美洲，脫髮症和雄性脫髮症的盛行率不斷上升正在推動市場的發展。除了越來越注重外表之外，多樣化的人口特徵也推動了對有效脫髮治療的需求。此外，大型製藥企業的存在、FDA 對新脫髮症治療藥物的核准迅速增加，以及對新治療方法研發的持續投資正在推動該地區的市場開拓。由於各種脫髮症的盛行率不斷增加以及患者對可用治療方案的認知不斷提高，亞太地區的脫髮症藥物行業呈現出廣闊的前景。在日本、中國、印度、韓國和澳洲等國家，由於都市區因壓力而出現更多脫髮，脫髮症治療的需求正在迅速增加。亞太地區的新興經濟體也在資助與皮膚病學和頭髮科學相關的研究舉措，以滿足不斷成長的需求。在 EMEA（歐洲、中東和非洲）地區，隨著消費者偏好隨著醫療技術的進步而發展，全球脫髮症藥物市場繼續保持積極的發展軌跡。消費者對有效治療方法的認知不斷提高以及政府改善醫療基礎設施的努力正在刺激這個多元化地區的成長機會。

FPNV定位矩陣

FPNV 定位矩陣對於評估脫髮症治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對脫髮症治療藥物市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-脫髮症治療藥物市場的市場規模和預測是多少？

2-在脫髮症治療藥物市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-脫髮症治療藥物市場的技術趨勢和法律規範是什麼？

4-脫髮症治療藥物市場主要供應商的市場佔有率是多少？

5-進入脫髮症藥市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球自體免疫疾病的盛行率增加
      • 不健康的生活方式和缺乏身體活動的現象正在增加
      • 提高人們對脫髮症狀況認知的非政府組織數量不斷增加
    • 抑制因素
      • 對脫髮症藥物及其有效性的負面健康影響的擔憂
    • 機會
      • 新監管機構核准脫髮症新系統治療方法
      • 加速脫髮症治療的研發活動
    • 任務
      • 毛髮移植和美容療程的需求迅速增加
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章脫髮症治療藥物市場：依脫髮症類型分類

  • 脫髮症
  • 全脫髮症
  • 脫髮症

第7章脫髮症治療藥物市場：依性別

  • 男性
  • 女士

第8章脫髮症治療藥物市場：依給藥途徑

  • 可注射的
  • 口服
  • 局部的

第9章 北美和南美脫髮症治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太脫髮症治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的脫髮症治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 併購
    • 獎項/獎勵/擴展

第13章競爭產品組合

  • 主要公司簡介
    • AndroScience Corporation
    • Capillus, LLC by Curallux, LLC
    • Cipla Inc.
    • Concert Pharmaceuticals, Inc.
    • Daiichi Sankyo Company, Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Eli Lilly and Company
    • Hairline Co.
    • Merck & Co., Inc.
    • The Himalaya Drug Company
    • Vitabiotics Ltd.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-436901065BAC

[187 Pages Report] The Alopecia Drugs Market size was estimated at USD 1.23 billion in 2023 and expected to reach USD 1.37 billion in 2024, at a CAGR 11.90% to reach USD 2.70 billion by 2030.

Global Alopecia Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.23 billion
Estimated Year [2024] USD 1.37 billion
Forecast Year [2030] USD 2.70 billion
CAGR (%) 11.90%
Alopecia Drugs Market - IMG1

Alopecia is a medical condition indicated by hair loss from the scalp or other body parts, affecting both males and females. Alopecia drugs serve as pharmacological interventions to prevent further hair loss, stimulate the regrowth of lost hair or address underlying causes. For instance, Finasteride is primarily utilized for treating androgenetic alopecia in men by inhibiting the enzyme 5-alpha-reductase responsible for converting testosterone into dihydrotestosterone (DHT) - a hormone linked to male pattern baldness. On the other hand, Minoxidil is a vasodilator initially developed to treat hypertension that has been approved for promoting hair growth in both sexes. Moreover, novel approaches, such as JAK inhibitors targeting Janus kinase proteins involved in immune signaling pathways or Platelet-Rich Plasma therapy harnessing growth factors from autologous blood samples, are under investigation. The global alopecia drugs market is experiencing significant growth due to the worldwide surging prevalence of autoimmune diseases, unhealthy lifestyle habits, and physical inactivity contributing to hair loss. Furthermore, numerous NGOs are actively working to raise awareness about alopecia, further fueling market growth. However, concerns about alopecia drugs' adverse health impacts and efficacy act as restraining factors for the market's expansion. Additionally, a surge in preference for hair growth transplants and cosmetic treatments may hinder the adoption of pharmaceutical interventions. On the other hand, emerging regulatory approvals for novel systemic therapies for alopecia areata offer lucrative opportunities for market players. Additionally, ongoing research and development activities in alopecia management bring promising prospects for future advancements.

Regional Insights

In the Americas, the market is primarily driven by a rising incidence of alopecia areata and male-pattern baldness. The increasing emphasis on aesthetic appearances combined with a diverse demographic profile contributes to the need for effective hair loss treatments. Moreover, the presence of leading pharmaceutical companies, surging FDA approvals for novel alopecia treatments, and continuous investments in research and development for novel therapies have bolstered market growth in this region. The APAC shows promising potential for the alopecia drug industry due to the increased prevalence of various hair loss disorders and growing patient awareness about available treatment options. Countries such as Japan, China, India, South Korea, and Australia are experiencing an upsurge in the need for alopecia drugs as their urban population experiences higher levels of stress-induced hair loss. Emerging economies in the APAC region are also funding research initiatives related to dermatology and trichology to meet growing needs. In the EMEA region, evolving consumer preferences alongside advances in medical technology continue to foster positive trajectories within the global alopecia drug market. Rising consumer awareness about effective treatments and government initiatives to improve healthcare infrastructure has stimulated growth opportunities within this diverse territory.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alopecia Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alopecia Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Drugs Market, highlighting leading vendors and their innovative profiles. These include AndroScience Corporation, Capillus, LLC by Curallux, LLC, Cipla Inc., Concert Pharmaceuticals, Inc., Daiichi Sankyo Company, Ltd., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Hairline Co., Merck & Co., Inc., The Himalaya Drug Company, and Vitabiotics Ltd..

Market Segmentation & Coverage

This research report categorizes the Alopecia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Alopecia Types
    • Alopecia Areata
    • Alopecia Totalis
    • Alopecia Universalis
  • Gender
    • Men
    • Women
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Alopecia Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alopecia Drugs Market?

3. What are the technology trends and regulatory frameworks in the Alopecia Drugs Market?

4. What is the market share of the leading vendors in the Alopecia Drugs Market?

5. Which modes and strategic moves are suitable for entering the Alopecia Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Alopecia Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of autoimmune diseases across the globe
      • 5.1.1.2. Surging adoption of unhealthy lifestyles and physical inactivity
      • 5.1.1.3. Increasing number of NGOs to create awareness about alopecia condition
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impact of alopecia drugs and concern with drugs efficacy
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging regulatory approvals for the novel systemic treatment for alopecia areata
      • 5.1.3.2. Accelerating research and developments activities for alopecia management
    • 5.1.4. Challenges
      • 5.1.4.1. Surge in preference for the hair growth transplant and cosmetic treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Alopecia Drugs Market, by Alopecia Types

  • 6.1. Introduction
  • 6.2. Alopecia Areata
  • 6.3. Alopecia Totalis
  • 6.4. Alopecia Universalis

7. Alopecia Drugs Market, by Gender

  • 7.1. Introduction
  • 7.2. Men
  • 7.3. Women

8. Alopecia Drugs Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Americas Alopecia Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Alopecia Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Alopecia Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. Sun Pharma to acquire US-based Concert Pharmaceuticals for USD 576 million
    • 12.3.2. Award, Recognition, & Expansion
      • 12.3.2.1. FDA Approves Pfizer's Alopecia Drug
      • 12.3.2.2. FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. AndroScience Corporation
    • 13.1.2. Capillus, LLC by Curallux, LLC
    • 13.1.3. Cipla Inc.
    • 13.1.4. Concert Pharmaceuticals, Inc.
    • 13.1.5. Daiichi Sankyo Company, Ltd.
    • 13.1.6. Dr. Reddy's Laboratories Ltd.
    • 13.1.7. Eli Lilly and Company
    • 13.1.8. Hairline Co.
    • 13.1.9. Merck & Co., Inc.
    • 13.1.10. The Himalaya Drug Company
    • 13.1.11. Vitabiotics Ltd.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ALOPECIA DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ALOPECIA DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ALOPECIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ALOPECIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ALOPECIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ALOPECIA DRUGS MARKET DYNAMICS
  • FIGURE 7. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2023 VS 2030 (%)
  • FIGURE 8. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 10. ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ALOPECIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ALOPECIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ALOPECIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ALOPECIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 6. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 10. ALOPECIA DRUGS MARKET SIZE, BY MEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ALOPECIA DRUGS MARKET SIZE, BY WOMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 13. ALOPECIA DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ALOPECIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ALOPECIA DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. ALOPECIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 144. ALOPECIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. ALOPECIA DRUGS MARKET LICENSE & PRICING